- PR Newswire•13 days ago
SEATTLE, Feb. 8, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that management will present at the the BIO CEO & Investor Conference on Tuesday, February ...
- PR Newswire•28 days ago
SEATTLE, Jan. 24, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that Michael A. Metzger has been appointed a Director of CTI BioPharma. Mr. Metzger brings extensive experience leading and growing companies in the biopharmaceutical industry over the last 20 years. "We are pleased to welcome Michael to the Board of CTI BioPharma," said Richard Love, Interim President and CEO of CTI BioPharma.
- Accesswire•last month
NEW YORK, NY / ACCESSWIRE / January 10, 2017 / The Dow Jones Industrial Average pulled back Monday after nearly breaking the 20,000 point plateau Friday. Declines by financial and energy sectors pressured ...
CTIC : Summary for CTI BioPharma Corp. - Yahoo Finance
CTI BioPharma Corp. (CTIC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.46 x 600|
|Ask||4.48 x 800|
|Day's Range||4.40 - 4.62|
|52 Week Range||0.31 - 6.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.59|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|